About this trial
Τhe aim of the study is to investigate the role of EEG both in predicting epileptogenesis in patients with acute stroke and in detecting and clarifying the clinical significance of subclinical epileptic seizures in a stroke unit. More specifically, the performance of routine EEG in patients with ischemic or hemorrhagic stroke who are hospitalized in the Stroke Unit within the first days after the event, regardless of the presence of clinical indications, and the identification of risk factors for the early development of epilepsy in the course of these patients' disease constitute the central research question. The identification of patients with subclinical electroencephalographic seizures and the impact of such events on functional outcome, as well as their association with the development of epilepsy, are set as secondary research objectives.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients with acute ischemic or hemorrhagic stroke in whom it is not possible to perform an electroencephalogram within the first 7 days after the event, as well as patients who themselves or their legal representatives do not consent to participation, will be excluded from the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
Routine EEG
Other interventionThe study is observational. No intervention is anticipated. Patients will be submitted to EEG recording within the first seven days of stroke
Routine EEG
Other interventionThe study is observational
Treatment groups
Trial outcomes
Primary outcomes
Incidence of post-stroke epilepsy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.